Incorporation of Ruxolitinib in the Management of Refractory/Relapsed Hodgkin Lymphoma: Where Do We Stand?

Saved in:
Bibliographic Details
Published in:Clinical hematology international 2023, Vol.5 (4), p.1-4
Main Authors: Al Sharie, Ahmed H, Abu Mousa, Balqis M, Alomari, Ahmad O
Format: Article
Language:English
Subjects:
Correspondence
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2590-0048
2590-0048
DOI:10.46989/001c.87501